OliX Pharmaceuticals, Inc (KOSDAQ:226950)

OliX Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,634,179	355,531	233,568	278,859	561,830	681,166
Market Cap Growth	1145.24%	52.22%	-16.24%	-50.37%	-17.52%	146.02%
Enterprise Value	3,527,546	392,701	247,386	238,494	524,125	657,538
Last Close Price	180000.00	19260.00	14580.00	20350.00	41000.00	50300.00
PS Ratio	356.94	62.63	13.69	29.92	152.91	275.30
PB Ratio	25.49	19.25	4.64	4.21	28.95	15.02
P/TBV Ratio	26.15	22.02	4.92	4.48	34.29	15.93
EV/Sales Ratio	-	69.17	14.50	25.59	142.64	265.75
Debt / Equity Ratio	0.16	2.12	0.78	0.67	1.92	0.32
Net Debt / Equity Ratio	-0.76	1.45	0.27	-0.27	-0.64	-1.18
Net Debt / EBITDA Ratio	4.07	-0.95	-0.86	0.88	0.55	3.55
Net Debt / FCF Ratio	6.91	-0.64	-0.45	0.54	0.61	11.79
Asset Turnover	0.08	0.07	0.14	0.09	0.04	0.04
Inventory Turnover	0.49	0.49	0.28	0.40	0.51	0.18
Quick Ratio	7.51	0.44	4.71	1.59	1.24	15.21
Current Ratio	7.61	0.52	4.90	1.65	1.29	15.38
Return on Equity (ROE)	-54.34%	-118.18%	-32.78%	-65.68%	-90.11%	-44.48%
Return on Assets (ROA)	-13.47%	-22.20%	-9.65%	-12.75%	-18.33%	-16.40%
Return on Capital Employed (ROCE)	-17.20%	-75.10%	-18.90%	-24.00%	-52.30%	-21.90%
Earnings Yield	-1.19%	-11.44%	-8.18%	-6.99%	-5.29%	-2.85%
FCF Yield	-0.43%	-11.68%	-12.84%	-11.80%	-3.62%	-0.67%
Buyback Yield / Dilution	-15.14%	-16.73%	-5.30%	-0.13%	-4.06%	-1.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.